Chipotle raised its same-store sales forecast while simultaneously explaining that cyclospora fears tanked sales in late July. Pick a lane. Either your burrito empire is crushing it or microscopic parasites are sending customers to Qdoba. Both cannot be true in the same earnings call.
The stock is down 7% this year. Market cap sits at $44 billion. Shareholders watched management stand up and say "Good news: we're hiking our forecast. Bad news: nobody wanted to eat here last month because of the brain worms." This is the corporate equivalent of proposing marriage during a herpes outbreak.
Cyclospora is a parasite that lives in feces. It causes intestinal distress for weeks. Someone at Chipotle looked at the sales data and thought "You know what'll reassure investors? Mentioning the poop parasite by name in the guidance update." Brilliant. Really threaded the needle on that messaging.
Retail traders saw the raised forecast and bought the dip. They always do. They read "same-store sales guidance increased" and their brains shut off before reaching "cyclospora outbreak." By the time they finish Googling how to spell cyclospora, they've already bought 12 shares at $58 and texted their cousin about it.
The chart doesn't care about your parasites. It doesn't care about your forecast. It moves on volume and volatility and the whims of algorithms that wouldn't eat at Chipotle if you paid them. Which you are, technically, if you own the stock.
Management raised guidance. Sales got crushed by a parasite. The stock is still down for the year. Everyone involved is pretending this makes sense. It's a perfect system: executives get paid to forecast growth, customers get dysentery, and retail traders get to explain to their spouses why they're down 11% on a restaurant chain that can't keep feces out of the guacamole.
Photo by on Unsplash
Leave a Comment